114 The glucose produced by this glycogen breakdown is exported into circulation which ensures sufficient plasma glucose levels so that glucose-dependent organs can produce enough ATP for their biological processes
Adding phentermine to tirzepatide provides sympathomimetic appetite suppression through a completely different pathway
Tirzepatide, compared to both GLP-1 and NNC0090-2746, shows biased signaling at GLP-1R, favoring cAMP response over -arrestin recruitment, which leads to low efficacy for GLP-1R internalization (108110)
While exact dosing varies, the microdosing GLP-1 approach generally includes: Starting with a lower dose than standard treatment (such as Ozempic or Mounjaro) to allow the body to adjust Gradual adjustments over time based on tolerance, appetite changes, and results Monitoring appetite, digestion, and energy levels to guide dosing decisions Tracking weight and overall progress to ensure the approach is effective Because GLP-1 medications affect metabolism and blood sugar, this approach should always be individualized